# Biodexa Pharmaceuticals Plc: Form 20-F for the period ended Dec 31, 2016

- Company: [Biodexa Pharmaceuticals Plc](/companies/bdrx.md) (CIK 1643918)
- Form: 20-F
- Filed: 2017-04-06
- Accepted by EDGAR: Apr 6, 2017, 08:59 ET
- Period: 2016-12-31
- Accession: 0001214659-17-002415
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1643918/000121465917002415/m4417020f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1643918/000121465917002415/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1643918/000121465917002415/m4417020f.htm

Filed Apr 6, 2017.
Source: SEC EDGAR, the filing index for accession 0001214659-17-002415. Last ingested by Listed: Nov 9, 2026, 17:57 ET. No prices; not investment advice.
